Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell, and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, and alpha-1 antitrypsin deficiency.
Serves as the central hub for Vertex's global operations, including research and development, corporate strategy, and administrative functions.
The headquarters comprises two interconnected, LEED Gold certified, state-of-the-art buildings at Fan Pier, featuring advanced research laboratories, collaborative workspaces, and views of Boston Harbor.
Emphasizes innovation, collaboration, and a patient-centric mission. The space is designed to foster interaction, scientific discovery, and employee well-being.
Represents Vertex's commitment to scientific excellence and its growth as a leading biotech firm. Its location in Boston's innovation hub facilitates collaboration with academic and medical institutions.
Vertex Pharmaceuticals operates globally with a network of offices and research sites across North America, Europe, Australia, and Latin America. Key functions supported globally include research and development, manufacturing and supply chain management, commercial operations, medical affairs, regulatory affairs, and essential corporate functions. This widespread presence is dedicated to discovering, developing, and delivering transformative medicines to patients with serious diseases worldwide.
50 Northern Avenue
Boston
MA
USA
Address: Level 9, The Point, 37 North Wharf Road, Paddington, London W2 1AF, UK
Supports the delivery of Vertex's transformative medicines to patients internationally and engages with regional healthcare systems, regulatory bodies, and stakeholders.
Address: 3215 Merryfield Row, San Diego, CA 92121, USA
Leverages the rich biotech ecosystem in San Diego to advance scientific research and development for new treatments for serious diseases.
Address: 88 Jubilee Avenue, Milton Park, Abingdon, OX14 4RW, UK
Contributes to Vertex's global R&D efforts by tapping into the UK's strong life sciences talent pool and world-class research infrastructure in the Oxford biotech cluster.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Vertex Pharmaceuticals' leadership includes:
Vertex Pharmaceuticals has been backed by several prominent investors over the years, including:
In the past 12 months, Vertex Pharmaceuticals notably strengthened its commercial leadership with the appointment of Paul M. Silva as Executive Vice President and Chief Commercial Officer. No other major C-suite executive departures or hires were prominently announced during this period based on available public information.
Discover the tools Vertex Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Vertex Pharmaceuticals commonly utilizes the email format combining the first initial directly followed by the last name, for its corporate communications (e.g., jdoe@vrtx.com). This format is prevalent across the organization.
first_initialLast@vrtx.com
Format
rKewalramani@vrtx.com
Example
90%
Success rate
Vertex Pharmaceuticals Press Release • May 29, 2024
Vertex and CRISPR Therapeutics announced they will present new data on CASGEVY, their gene-editing therapy, demonstrating consistent and sustained clinical benefits for patients with sickle cell disease and transfusion-dependent beta thalassemia, including improvements in quality of life....more
Vertex Pharmaceuticals Press Release • May 7, 2024
Vertex announced robust financial performance for Q1 2024, highlighted by a 13% increase in product revenue to $2.69 billion, driven by strong sales of its cystic fibrosis treatments, and reaffirmed its full-year 2024 financial guidance. The company also emphasized continued investment in its diverse R&D pipeline....more
Vertex Pharmaceuticals Press Release • April 2, 2024
Vertex reported successful results from two pivotal Phase 3 trials (SKYLINE 102 and SKYLINE 103) of its next-generation vanzacaftor/tezacaftor/deutivacaftor triple combination therapy for cystic fibrosis in patients 12 years and older. The therapy showed statistically significant improvements in lung function and other key measures, with plans for global regulatory submissions by mid-2024....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Vertex Pharmaceuticals, are just a search away.